- Home
- ANTX vs PIII Comparison
ANTX vs PIII Comparison
Compare ANTX & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- PIII
- Stock Information
- Founded
- ANTX 2017
- PIII 2015
- Country
- ANTX United States
- PIII United States
- Employees
- ANTX N/A
- PIII N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- PIII Medical/Nursing Services
- Sector
- ANTX Health Care
- PIII Health Care
- Exchange
- ANTX Nasdaq
- PIII Nasdaq
- Market Cap
- ANTX 34.4M
- PIII 27.8M
- IPO Year
- ANTX 2022
- PIII N/A
- Fundamental
- Price
- ANTX $1.23
- PIII N/A
- Analyst Decision
- ANTX Buy
- PIII Strong Buy
- Analyst Count
- ANTX 2
- PIII 3
- Target Price
- ANTX $2.00
- PIII $17.50
- AVG Volume (30 Days)
- ANTX 59.2K
- PIII 9.0K
- Earning Date
- ANTX 11-12-2025
- PIII 11-11-2025
- Dividend Yield
- ANTX N/A
- PIII N/A
- EPS Growth
- ANTX N/A
- PIII N/A
- EPS
- ANTX N/A
- PIII N/A
- Revenue
- ANTX N/A
- PIII $1,461,823,000.00
- Revenue This Year
- ANTX N/A
- PIII N/A
- Revenue Next Year
- ANTX N/A
- PIII $10.45
- P/E Ratio
- ANTX N/A
- PIII N/A
- Revenue Growth
- ANTX N/A
- PIII 4.20
- 52 Week Low
- ANTX $0.98
- PIII $5.80
- 52 Week High
- ANTX $1.68
- PIII $26.00
- Technical
- Relative Strength Index (RSI)
- ANTX 48.81
- PIII 50.52
- Support Level
- ANTX $1.18
- PIII $8.65
- Resistance Level
- ANTX $1.30
- PIII $9.25
- Average True Range (ATR)
- ANTX 0.07
- PIII 0.48
- MACD
- ANTX -0.01
- PIII -0.07
- Stochastic Oscillator
- ANTX 29.91
- PIII 18.52
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.